Health and population

Health and population dynamics are intertwined, embodying an intricate relationship with significant implications on the Sustainable Development Goals (SDGs). Health is fundamentally at the center of these 17 global goals, aimed to transform the world by 2030. Specifically, Goal 3 endeavors to "Ensure healthy lives and promote well-being for all at all ages." It acknowledges that health is pivotal to human life quality, social cohesion, and sustainable development. Inextricably linked to this are the complexities of population dynamics, including growth rates, age structure, fertility and mortality rates, and migration patterns.

With the world's population projected to exceed 9.7 billion by 2050, the pressure on health systems will undoubtedly escalate. The demographic transition, with an aging population and an increasing prevalence of non-communicable diseases, poses new challenges for health systems globally. Additionally, areas with high fertility rates often overlap with extreme poverty, resulting in heightened health risks, including higher maternal and child mortality rates, malnutrition, and infectious diseases.

Moreover, rapid urbanization and migration present both opportunities and threats to health. While urban areas may provide better access to healthcare, they also harbor risks of disease transmission, air and water pollution, and social determinants of health like inadequate housing and social inequality. Simultaneously, migrants often face disproportionate health risks due to unstable living conditions, exploitation, and limited access to healthcare services.

Achieving the SDGs will necessitate comprehensive approaches that consider the intricate interplay of health and population dynamics. It means strengthening health systems, promoting universal health coverage, and addressing social determinants of health. It also implies crafting policies that recognize demographic realities and foster an environment conducive to sustainable development. Only by understanding and harnessing these dynamics can the world meaningfully progress towards realizing the SDGs, ensuring healthy lives and well-being for all.

Elsevier, Neurobiology of Stress, Volume 8, February 2018
Clinical studies indicate that Alzheimer's disease (AD) disproportionately affects women in both disease prevalence and severity, but the mechanisms underlying this sex divergence are unknown. Though some have suggested this difference in risk is a reflection of known differences in longevity between men and women, mounting clinical and preclinical evidence supports women also having intrinsic susceptibilities towards the disease. While a number of potential risk factors have been hypothesized to affect these differences in risks, none have been definitively verified.
Elsevier,

Hematology/Oncology Clinics of North America, Volume 32, Issue 1, February 2018, Pages 11-21

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing a summary of current understanding of the cause, cell types, signaling pathways, and effector cytokines implicated in pathogenesis.
Elsevier, Smart Wheelchairs and Brain-computer Interfaces: Mobile Assistive Technologies, Volume , 1 January 2018
Smart Wheelchairs and Brain-Computer Interfaces: Mobile Assistive Technologies combines the fields of neuroscience, rehabilitation and robotics via contributions from experts in their field to help readers develop new mobile assistive technologies. It provides information on robotics, control algorithm design for mobile robotics systems, ultrasonic and laser sensors for measurement and trajectory planning, and is ideal for researchers in BCI.
The Lancet Report - Stillbirth in low and middle-income countries
Highlighting the data behind stillbirths to bring about change, this article and video supports SDG 3. 2.6 million babies worldwide are stillborn each year. The majority of these are preventable. The Lancet partnered with the London School of Hygiene & Tropical Medicine to find solutions to end this silent scandal.
Elsevier,

Sexual Assault Risk Reduction and Resistance: Theory, Research, and Practice, 2018, Pages 291-308

Advancing SDGs 3 and 5, this chapter provides an overview of the global prevalence of sexual violence and a summary of empirically supported approaches to reduce risk of sexual violence and identifies promising directions for future research.
Objectives Gender identity disorder is defined as a strong and persistent cross-gender identification that is associated with a remarkable uneasiness of living in an incongruent gender (gender dysphoria). We performed a retrospective study on the hormonal and metabolic effects of cross-sex hormone therapy (CSHT) in a small cohort of transgender patients. Study design Retrospective study. Mean outcome measures Hormonal and biochemical parameters at baseline (i.e.
A human-centered design thinking approach has been applied to a course at the MIT D-Lab on creating low-cost prosthetic and assistive devices for the developing world. Teams of students with diverse backgrounds are paired with international stakeholders and industry partners to tackle real-world prosthetic technology needs, learn the design process through interactive lectures and workshops in the classroom, and are given the opportunity to conduct testing of the prototypes generated during the semester at field sites around the globe.
Elsevier,

The Liver, Oxidative Stress and Dietary Antioxidants, 2018, Pages 71-78

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the role of AGEs and RAGE in liver fibrosis and inflammation.
This report seeks to provide an in-depth review of SDG 6 and includes data on the global baseline status, the current situation and trends at global and regional levels, and what more needs to be done to achieve this goal by 2030. The report is based on the latest data available for the 11 SDG 6 global indicators selected by Member States to track progress towards the eight global targets, plus complementary data and evidence from a wide range of sources.
Elsevier, The Lancet Gastroenterology and Hepatology, Volume 2, December 2017
The WHO global health sector strategy on viral hepatitis, created in May, 2016, aims to achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in mortality due to hepatitis B and C by 2030. Hepatitis B virus (HBV) is endemic in sub-Saharan Africa, and despite the introduction of universal hepatitis B vaccination and effective antiviral therapy, the estimated overall seroprevalence of hepatitis B surface antigen remains high at 6·1% (95% uncertainty interval 4·6–8·5).

Pages